TAKTakeda Pharmaceutical Company Limited

TAK Stock Price, Valuation & Chart | Takeda Pharmaceutical Company Limited

$18.430+0.20 (+1.10%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic TAK intrinsic value TAK calculated fair value vs price

Overview Financials Dividends Ratios

TAK Historical price chart

TAK Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization58.65B

PE Ratio13.25

EPS1.39

Trading Volume1.72M

Today's High/Low18.5/18.3

Dividend Yield3.43

52 Week High/Low18.9/12.99

Shares Outstanding3.18B

TAK Financial Statement

TAK Analyst ratings

TAK Analysis & performance metrics

TAK Company profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States,…

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The…

TAK Management team

Name

Position

Norimasa Takeda

Chief Accounting Officer & Corporate Controller

Iwaaki Taniguchi

Senior Vice President of Corporate Finance & Controlling Department

Haruhiko Hirate

Member of Management Board

Seigo Izumo

Chair of Management Board

Christophe WeberCEO

President, Chief Executive Officer & Representative Director

Gabriele Ricci

Chief Data & Technology Officer

Christopher David O'Reilly

Global Head of Investor Relations & Global Finance

Milano FurutaCFO

Chief Financial Officer & Director

Name

Position

Norimasa Takeda

Chief Accounting Officer & Corporate Controller

Iwaaki Taniguchi

Senior Vice President of Corporate Finance & Controlling Department

Haruhiko Hirate

Member of Management Board

Seigo Izumo

Chair of Management Board

Christophe WeberCEO

President, Chief Executive Officer & Representative Director

Gabriele Ricci

Chief Data & Technology Officer

Christopher David O'Reilly

Global Head of Investor Relations & Global Finance

Milano FurutaCFO

Chief Financial Officer & Director

Management Team

Norimasa Takeda

Chief Accounting Officer & Corporate Controller

Iwaaki Taniguchi

Senior Vice President of Corporate Finance & Controlling Department

Haruhiko Hirate

Member of Management Board

Seigo Izumo

Chair of Management Board

Christophe WeberCEO

President, Chief Executive Officer & Representative Director

Gabriele Ricci

Chief Data & Technology Officer

Christopher David O'Reilly

Global Head of Investor Relations & Global Finance

Milano FurutaCFO

Chief Financial Officer & Director

Management

Norimasa Takeda

Chief Accounting Officer & Corporate Controller

Iwaaki Taniguchi

Senior Vice President of Corporate Finance & Controlling Department

Haruhiko Hirate

Member of Management Board

Seigo Izumo

Chair of Management Board

Christophe WeberCEO

President, Chief Executive Officer & Representative Director

Gabriele Ricci

Chief Data & Technology Officer

Christopher David O'Reilly

Global Head of Investor Relations & Global Finance

Milano FurutaCFO

Chief Financial Officer & Director

Total 8 executives

TAK Frequently asked questions

What is Takeda Pharmaceutical Company Limited (TAK) Stock Price?

Current stock price of Takeda Pharmaceutical Company Limited (TAK) stock is $18.430. The stock price is +1.10% higher in the session. The intraday range can be seen from this page. Volume of Takeda Pharmaceutical Company Limited (TAK) stock is 1.72M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Takeda Pharmaceutical Company Limited (TAK) stock price going up or down today?

The stock price of Takeda Pharmaceutical Company Limited (TAK) can change with earnings, company news, and overall market sentiment. Takeda Pharmaceutical Company Limited operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Takeda Pharmaceutical Company Limited stock expensive at its current price?

Whether Takeda Pharmaceutical Company Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TAK on this page is 13.25. EPS on this page is 1.39. Compare those figures with peers and growth expectations before deciding if the current Takeda Pharmaceutical Company Limited price is justified.

How has the stock price of Takeda Pharmaceutical Company Limited (TAK) performed historically?

Historical performance for Takeda Pharmaceutical Company Limited (TAK) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TAK reacted to past earnings and market events.

Should I buy Takeda Pharmaceutical Company Limited (TAK) stock, at this price?

Buying Takeda Pharmaceutical Company Limited (TAK) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.